StocksVir Biotechnology IncVIR

VIR

Vir Biotechnology Inc

23.64 -0.49 (-2.04%)
الأسعار المؤجلة من قبل NASDAQ، بـ USD فتح السوق
صفقة
S
23.64
B
23.81
الأعلى
Genome Engineering
المملكة المتحدة
Dear Investors, Here is your monthly update for April 2022. Financial markets struggled across the board in April as the continuing Russia-Ukraine conflict, as well as fears over more aggressive central bank interventions, weighed down markets. Find out more about what happened in April with eToro's... عرض المزيد ترجم
Paul Connolly
جزيرة آيل أوف مان
$VIR (Vir Biotechnology Inc) Vir Biotechnology (NASDAQ:VIR) announced its quarterly results after the market closed on Thursday, May 5th. The company reported $3.85 earnings per share (EPS) for the previous quarter, beating the consensus estimate of $3.78 EPS by $0.07. The company had revenue of $1.20... عرض المزيد ترجم
VIR
Vir Biotechnology Inc
23.64
-0.49 (-2.04%)
صفقة
MarketUpdates
المملكة المتحدة
من المُقرر أن تُصدر $VIR (Vir Biotechnology Inc) تقرير أرباحها للربع 2 2022. ماذا يعني ذلك بالنسبة للتوقعات التالية؟
4
أغسطس
التقارير
من المُقرر أن يصدر تقرير أرباح Vir Biotechnology Inc للربع2 2022 بعد فتح الأسواق
إخطار
VIR
VIR
Vir Biotechnology Inc
23.64
-0.49
(-2.04%)
صفقة
MarketUpdates
المملكة المتحدة
$VIR (Vir Biotechnology Inc) Q2 2022 earnings report is expected to be released ترجم
Paul Connolly
جزيرة آيل أوف مان
$VIR (Vir Biotechnology Inc) Vir Biotechnology, Inc. (NASDAQ:VIR) Director Vicki L. Sato sold 17,915 shares of the company's stock in a transaction that occurred on Thursday, April 28th. The shares were sold at an average price of $20.90, for a total transaction of $374,423.50. Following the completion... عرض المزيد ترجم
VIR
Vir Biotechnology Inc
23.64
-0.49 (-2.04%)
صفقة